Lentiviral hematopoietic stem and progenitor cell gene therapy (HSPC-GT) for metachromatic leukodystrophy (MLD): Clinical outcomes from 33 patients
Keyword(s):
Keyword(s):
2018 ◽
Vol 53
(7)
◽
pp. 913-917
◽
2021 ◽
Vol 385
(21)
◽
pp. 1929-1940
◽
Keyword(s):